This initiative has been designed to address the educational needs of clinicians, including physicians, nurse practitioners (NPs), PAs, and clinical pharmacists. It may also benefit primary care practitioners (PCPs) and other clinicians who are interested or involved in the care of patients with risk factors for cardiovascular disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Pricing
CME included with membership · $195/yr
| Regular Membership (1 year) | $195/yr |
| Regular Membership (3 years) | $510 |
| International Membership (1 year) | $195/yr |
| International Membership (3 years) | $510 |
| Industry Membership (1 year) | $195/yr |
| Industry Membership (3 years) | $510 |
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedJan 5, 2026
-
Last day to claim creditJan 6, 2027 3 months left
-
Medscape, LLC Gene Therapies in Parkinson Disease: Defining Needs and Tracking the Progress of Clinical Development
-
Pri-Med Institute Heart Smart: Managing Hypertension and Hypercholesterolemia in Primary Care
-
Answers in CME Inc. (AiCME) HoFH in Focus: Practical Strategies for Early Detection and Lifelong Management
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Treatment Strategies and Targets: Podcast
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Understanding the New Dyslipidemia Paradigm: Podcast
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Non-Statin Therapies and Emerging Treatments: Podcast
